Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26135962 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sanja Glisic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Cyproheptadine, Antiviral Agents, Influenza A virus. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia, NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseas-es, EU’s NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
Influenza is still a chronic global health threat, inducing a sustained search for effective antiviral therapeutics. Computational methods have played a pivotal role in developing small molecule therapeutics. In this study, we applied a combined in silico and in vitro approach to explore the potential anti-influenza activity of cyproheptadine, a clinically used histamine H1 receptor antagonist. Virtual screening based on the average quasivalence number (AQVN) and electron–ion interaction potential (EIIP) descriptors suggests similarities between cyproheptadine and several established anti-influenza agents. The subsequent ligand-based pharmacophore screening of a focused H1 antagonist library was aligned with the bioinformatics prediction, and further experimental in vitro evaluation of cyproheptadine demonstrated its anti-influenza activity. These findings provide proof of concept for cyproheptadine’s in silico-predicted antiviral potential and underscore the value of integrating computational predictions with experimental validation. The results of the current study provide a preliminary proof of concept for the predicted anti-influenza potential based on computational analysis and emphasize the utility of integrating in silico screening with experimental validation in the early stages of drug repurposing efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, 11000 Belgrade, Serbia.
- Theory Department, National Institute of Chemistry, 1000 Ljubljana, Slovenia.
- Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
- Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77550, USA.
- Infection Biology Laboratory, Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), 08003 Barcelona, Spain.
ORCID-Profile: Sanja Glisic, Kristina Stevanovic, Andrej Perdih, Junki Maruyama, Vladimir Perovic, Sergi López-Serrano, Milan Sencanski, Bruno Botta, Mattia Mori
Förderung
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
- NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseas-es
- EU’s NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Glisic, S., Stevanovic, K., Perdih, A., Bukreyeva, N., Maruyama, J., Perovic, V., López-Serrano, S., Darji, A., Radosevic, D., Sencanski, M., Veljkovic, V., Botta, B., Mori, M., & Paessler, S. (2025). Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135962
Vancouver
Glisic S, Stevanovic K, Perdih A, Bukreyeva N, Maruyama J, Perovic V, et al. Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135962
BibTeX
@article{Glisic2025,
author = {Glisic, Sanja and Stevanovic, Kristina and Perdih, Andrej and Bukreyeva, Natalya and Maruyama, Junki and Perovic, Vladimir and López-Serrano, Sergi and Darji, Ayub and Radosevic, Draginja and Sencanski, Milan and Veljkovic, Veljko and Botta, Bruno and Mori, Mattia and Paessler, Slobodan},
title = {Influenza a Virus Inhibition: Evaluating Computationally Identified Cyproheptadine Through In Vitro Assessment},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26135962}
}
EUVIMED